USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND
The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated sk...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DAN, Mo QIN, Ning ZHANG, Hancheng LIU, Xibao LYU, Lu LIU, Jieru ZHANG, Dandan CAI, Congcong YANG, Hanyu |
description | The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022234495A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022234495A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022234495A13</originalsourceid><addsrcrecordid>eNrjZNAPDXZV8HdTCAnydI509vF0VvBwDXEN8ncMivTRdfb3C3H09PP0c1dw9vcN8A_1c-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGRkZGxiYmlqaOhsbEqQIAsq8nCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><source>esp@cenet</source><creator>DAN, Mo ; QIN, Ning ; ZHANG, Hancheng ; LIU, Xibao ; LYU, Lu ; LIU, Jieru ; ZHANG, Dandan ; CAI, Congcong ; YANG, Hanyu</creator><creatorcontrib>DAN, Mo ; QIN, Ning ; ZHANG, Hancheng ; LIU, Xibao ; LYU, Lu ; LIU, Jieru ; ZHANG, Dandan ; CAI, Congcong ; YANG, Hanyu</creatorcontrib><description>The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240627&DB=EPODOC&CC=AU&NR=2022234495A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25553,76306</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240627&DB=EPODOC&CC=AU&NR=2022234495A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAN, Mo</creatorcontrib><creatorcontrib>QIN, Ning</creatorcontrib><creatorcontrib>ZHANG, Hancheng</creatorcontrib><creatorcontrib>LIU, Xibao</creatorcontrib><creatorcontrib>LYU, Lu</creatorcontrib><creatorcontrib>LIU, Jieru</creatorcontrib><creatorcontrib>ZHANG, Dandan</creatorcontrib><creatorcontrib>CAI, Congcong</creatorcontrib><creatorcontrib>YANG, Hanyu</creatorcontrib><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><description>The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPDXZV8HdTCAnydI509vF0VvBwDXEN8ncMivTRdfb3C3H09PP0c1dw9vcN8A_1c-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGRkZGxiYmlqaOhsbEqQIAsq8nCw</recordid><startdate>20240627</startdate><enddate>20240627</enddate><creator>DAN, Mo</creator><creator>QIN, Ning</creator><creator>ZHANG, Hancheng</creator><creator>LIU, Xibao</creator><creator>LYU, Lu</creator><creator>LIU, Jieru</creator><creator>ZHANG, Dandan</creator><creator>CAI, Congcong</creator><creator>YANG, Hanyu</creator><scope>EVB</scope></search><sort><creationdate>20240627</creationdate><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><author>DAN, Mo ; QIN, Ning ; ZHANG, Hancheng ; LIU, Xibao ; LYU, Lu ; LIU, Jieru ; ZHANG, Dandan ; CAI, Congcong ; YANG, Hanyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022234495A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAN, Mo</creatorcontrib><creatorcontrib>QIN, Ning</creatorcontrib><creatorcontrib>ZHANG, Hancheng</creatorcontrib><creatorcontrib>LIU, Xibao</creatorcontrib><creatorcontrib>LYU, Lu</creatorcontrib><creatorcontrib>LIU, Jieru</creatorcontrib><creatorcontrib>ZHANG, Dandan</creatorcontrib><creatorcontrib>CAI, Congcong</creatorcontrib><creatorcontrib>YANG, Hanyu</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAN, Mo</au><au>QIN, Ning</au><au>ZHANG, Hancheng</au><au>LIU, Xibao</au><au>LYU, Lu</au><au>LIU, Jieru</au><au>ZHANG, Dandan</au><au>CAI, Congcong</au><au>YANG, Hanyu</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND</title><date>2024-06-27</date><risdate>2024</risdate><abstract>The present application provides the use of a compound (I) or an optical isomer or pharmaceutically acceptable salt thereof in preparation of a medicament for treating JAK and SYK kinase high expression or abnormal activation related diseases, including autoimmune diseases such as immune-mediated skin diseases, particularly psoriasis, atopic dermatitis, and SLE. The compound (I) or the optical isomer or pharmaceutically acceptable salt thereof in the present invention can mitigate skin lesions of mice suffering from psoriasis, atopic dermatitis, and SLE, relieves renal injury, inhibits enlargement of immune organs, reduces the level of inflammation, inhibits increase of SLE-related antibodies and cytokines in serum, has a certain safe therapeutic window, and has good prospects of clinical application.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2022234495A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | USE OF TRICYCLIC HETEROARYL-CONTAINING COMPOUND |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T08%3A50%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAN,%20Mo&rft.date=2024-06-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022234495A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |